Bristol-Myers Squibb Company ( NYSE:BMY ) stock is about to trade ex-dividend in two days. The ex-dividend date is ...
Dividend investing can create substantial passive income over time. A conservative example illustrates this potential: ...
A Relative Strength Rating upgrade for Bristol Myers Squibb shows improving technical performance. Will it continue?
With a drug in advanced testing for two different indications that have spawned several blockbuster drugs, could Alumis be ...
Leerink Partners analyst David Risinger has maintained their neutral stance on BMY stock, giving a Hold rating on September 26. David Risinger ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.